Consenso europeo para el tratamiento de los pacientes con carcinoma tiroideo diferenciado del epitelio folicular

Coleman PM, Babb P, Damiecky P, Groslaude P, Honjo S, Jones J, et al. Cancer Survival Trends in England and Wales 1971-1995: Deprivation and NHS Region Series SMPS no. 61. London: Stationery Office; 1999. p. 471-8. Hodgson, 2004, Thyroid cancer: is the incidence still increasing?, Ann Surg Oncol, 11, 1093, 10.1245/ASO.2004.03.066 2002 Rodrigues, 2005, Protocol for the treatment and follow-up of differentiated follicular thyroid carcinomas, Portuguese Medical Minutes, 18, 2 Trattamento e Follow-up del Carcinoma Tiroideo Differenziato Della Tiroide. Linee Guida SIE-AIMN-AIFM; 2004. p. 1-75. Van De Velde, 1988, Report of the consensus development conference on the management of differentiated thyroid cancer in The Netherlands, Eur J Cancer Clin Oncol, 24, 287, 10.1016/0277-5379(88)90270-2 Pacini, 2004, Management of thyroid nodules: a clinicopathological, evidence-based approach, Eur J Nuclear Med Mol Imaging, 31, 1443, 10.1007/s00259-004-1680-0 Belfiore, 1992, Cancer risk in patients with cold thyroid nodules: relevance of iodine uptake, sex, age, and multinodularity, Am J Med, 93, 363, 10.1016/0002-9343(92)90164-7 Marqusee, 2000, Usefulness of ultrasonography in the management of nodular thyroid disease, Ann Intern Med, 133, 696, 10.7326/0003-4819-133-9-200011070-00011 Frates, 2005, Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement, Radiology, 237, 794, 10.1148/radiol.2373050220 Hegedus, 2001, Thyroid ultrasound, Endocrinol Metab Clin North Am, 30, 339, 10.1016/S0889-8529(05)70190-0 Cap, 1999, Sensitivity and specificity of the fine needle aspiration biopsy of the thyroid: clinical point of view, Clin Endocrinol, 51, 509, 10.1046/j.1365-2265.1999.00847.x Braga, 2001, Efficacy of ultrasound-guided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules, J Clin Endocrinol Metab, 86, 4089, 10.1210/jc.86.9.4089 Mulcahy, 1998, Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of well-differentiated thyroid cancer, Laryngoscope, 104, 494, 10.1097/00005537-199804000-00006 Giuffrida, 2000, Anaplastic thyroid cancer: current diagnosis and treatment, Ann Oncol, 11, 1083, 10.1023/A:1008322002520 Mazzaferri, 1994, Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer, Am J Med, 49, 418, 10.1016/0002-9343(94)90321-2 Goldstein, 2002, Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules, Ann Surg, 235, 656, 10.1097/00000658-200205000-00007 Guarino, 2005, Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer, Thyroid, 15, 1041, 10.1089/thy.2005.15.1041 Elisei, 2004, Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders, J Clin Endocrinol Metab, 89, 163, 10.1210/jc.2003-030550 Niccoli, 1997, Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group, J Clin Endocrinol Metab, 82, 338, 10.1210/jc.82.2.338 Rieu, 1995, CT prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules, Clin Endocrinol (Oxford), 42, 453, 10.1111/j.1365-2265.1995.tb02662.x Vierhapper, 1997, Routine measurement of plasma calcitonin in nodular thyroid diseases, J Clin Endocrinol Metab, 82, 1589, 10.1210/jc.82.5.1589 Shimamoto, 1998, Preoperative staging of thyroid papillary carcinoma with ultrasonography, Eur J Radiol, 29, 4, 10.1016/S0720-048X(97)00184-8 Esnaola, 2001, Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis, Surgery, 130, 921, 10.1067/msy.2001.118370 Hay, 1993, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989, Surgery, 114, 1050 Hay, 1998, Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?, Surgery, 124, 958, 10.1016/S0039-6060(98)70035-2 Hundahl, 2000, Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996, Cancer, 89, 202, 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A Machens, 2005, The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma, Cancer, 103, 2269, 10.1002/cncr.21055 Gardner, 2000, Prognostic importance of vascular invasion in papillary thyroid carcinoma, Arch Otolaryngol Head Neck Surg, 126, 309, 10.1001/archotol.126.3.309 Pacini, 2001, Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients, Thyroid, 11, 877, 10.1089/105072501316973145 Machens, 2001, Prophylactic completion thyroidectomy for differentiated thyroid carcinoma: prediction of extrathyroidal soft tissue infiltrates, Thyroid, 11, 381, 10.1089/10507250152039136 Randolph, 2002, Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid, Thyroid, 12, 989, 10.1089/105072502320908321 Ito, 2004, Preoperative ultrasonographic examination for lymph node metastases: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid, World J Surg, 28, 498, 10.1007/s00268-004-7192-z Machens, 2002, Pattern of nodal metastasis for primary and reoperative thyroid cancer, World J Surg, 26, 22, 10.1007/s00268-001-0176-3 Scheumann, 1994, Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer, World J Surg, 18, 559, 10.1007/BF00353765 Tisell, 1996, Improved survival of patients with papillary thyroid cancer after surgical microdissection, World J Surg, 20, 854, 10.1007/s002689900130 Dralle, 2005, Surgical management of advanced thyroid cancer invading the aerodigestive tract, 318 Thomusch, 2001, Analysis of surgery-related complications in thyroid carcinoma –a German prospective multi-centre study with 275 patients, Acta Chirurgica Austriaca, 33, 194, 10.1046/j.1563-2563.2001.01155.x Hartl, 2005, Current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery, J Clin Endocrinol Metab, 90, 3084, 10.1210/jc.2004-2533 Samaan, 1992, The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients, J Clin Endocrinol Metab, 75, 714, 10.1210/jc.75.3.714 Mazzaferri, 1994, Differentiated thyroid cancer: long-term impact of initial therapy, Transactions of the American Clinical and Climatological Association, 106, 151 Taylor, 1998, Outcome after treatment of high-risk papillary and non-Hurthlecell follicular thyroid carcinoma, Ann Intern Med, 129, 622, 10.7326/0003-4819-129-8-199810150-00007 Sawka, 2004, Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer, J Clin Endocrinol Metab, 89, 3668, 10.1210/jc.2003-031167 Pacini, 2005, Post surgical use of radioiodine (I-131) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation. A consensus report, Eur J Endocrinol, 153, 651, 10.1530/eje.1.02014 Schroder, 2006, A comparison of short term changes in health related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with rhTSH compared to thyroid hormone withdrawal, J Clin Endocrinol Metab, 91, 878, 10.1210/jc.2005-2064 Schlumberger, 1980, Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels, J Clin Endocrinol Metab, 51, 513, 10.1210/jcem-51-3-513 Robbins, 2002, A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation, J Nuclear Med, 43, 1482 Pacini, 2006, Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study, J Clin Endocrinol Metab, 91, 926, 10.1210/jc.2005-1651 Park, 1997, Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma, Thyroid, 7, 277, 10.1089/thy.1997.7.277 Hilditch, 2002, Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic I-131 and I-123, Eur J Nuclear Med Mol Imaging, 29, 783, 10.1007/s00259-002-0785-6 Lassmann, 2004, Impact of 131I diagnostic activities on the biokinetics of thyroid remnants, J Nuclear Med, 45, 619 Pluijmen, 2003, Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma, Clin Endocrinol (Oxford), 58, 428, 10.1046/j.1365-2265.2003.01735.x Fatourechi, 2000, Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?, Thyroid, 10, 573, 10.1089/thy.2000.10.573 Sherman, 1994, Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma, J Clin Endocrinol Metab, 78, 629, 10.1210/jc.78.3.629 Hay, 1993, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989, Surgery, 114, 1050 Hay, 2002, Papillary thyroid carcinoma managed at the May Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients, World J Surg, 8, 879, 10.1007/s00268-002-6612-1 Byar, 1979, A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group, Eur J Cancer, 15, 1033, 10.1016/0014-2964(79)90291-3 Tenvall, 1986, Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up, Cancer, 57, 1405, 10.1002/1097-0142(19860401)57:7<1405::AID-CNCR2820570728>3.0.CO;2-O Shaha, 1995, Prognostic factors and risk group analysis in follicular carcinoma of the thyroid, Surgery, 118, 1131, 10.1016/S0039-6060(05)80124-2 Sherman, 1998, Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group, Cancer, 83, 1012, 10.1002/(SICI)1097-0142(19980901)83:5<1012::AID-CNCR28>3.0.CO;2-9 Links, 2005, Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis, Endocrine-related Cancer, 12, 272, 10.1677/erc.1.00892 Wittekind, 2002, TNM residual tumor classification revisited, Cancer, 94, 2511, 10.1002/cncr.10492 Cooper, 1998, Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry, Thyroid, 8, 737, 10.1089/thy.1998.8.737 McGriff, 2002, Effects of thyroid hormone suppression therapy on adverse. clinical outcomes in thyroid cancer, Ann Med, 34, 554, 10.1080/078538902321117760 Baudin, 2003, Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients, J Clin Endocrinol Metab, 88, 1107, 10.1210/jc.2002-021365 Schlumberger, 2004, Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective, Eur J Endocrinol, 150, 105, 10.1530/eje.0.1500105 Biondi, 2005, Thyroid-hormone therapy and thyroid cancer: a reassessment, Nat Clin Pract Endocrinol Metab, 1, 32, 10.1038/ncpendmet0020 Horne, 2004, Is thyroid hormone suppression therapy prothrombotic?, J Clin Endocrinol Metab, 89, 4469, 10.1210/jc.2004-0536 Feldt-Rasmussen, 1996, Human thyroglobulin reference material (CRM 457). 1st part: assessment of homogeneity, stability and immunoreactivity, Annales de Biologie Clinique (Paris), 54, 337 Feldt-Rasmussen, 1996, Human thyroglobulin reference material (CRM 457). 2nd part: physicochemical characterization and certification, Annales de Biologie Clinique (Paris), 54, 343 Chiovato, 2003, Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens, Ann Intern Med, 139, 346, 10.7326/0003-4819-139-5_Part_1-200309020-00010 Cailleux, 2000, Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid carcinoma?, J Clin Endocrinol Metab, 85, 175, 10.1210/jc.85.1.175 Pacini, 2002, Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment, J Clin Endocrinol Metab, 87, 1499, 10.1210/jc.87.4.1499 Pacini, 2003, Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma, J Clin Endocrinol Metab, 88, 3668, 10.1210/jc.2002-021925 Torlontano, 2004, Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases, J Clin Endocrinol Metab, 89, 3402, 10.1210/jc.2003-031521 Pacini, 2001, Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma, J Clin Endocrinol Metab, 86, 5686, 10.1210/jc.86.12.5686 Schlumberger, 1988, Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays, J Nuclear Med, 29, 1790 Pineda, 1995, Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan, J Clin Endocrinol Metab, 80, 1488, 10.1210/jc.80.5.1488 Pacini, 2001, Outcome of differentiated thyroid cancer with detectable serum thyroglobulin and negative diagnostic 131I whole body scan: comparison of patients treated with high 131I activities versus untreated patients, J Clin Endocrinol Metab, 86, 4092, 10.1210/jc.86.9.4092 Luster, 2005, rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review, Endocrine-related Cancer, 12, 49, 10.1677/erc.1.00830 Haugen, 1999, A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer, J Clin Endocrinol Metab, 84, 3877, 10.1210/jc.84.11.3877 Driedger, 2004, Two cases of thyroid carcinoma that were not stimulated by recombinant human thyrotropin, J Clin Endocrinol Metab, 89, 585, 10.1210/jc.2003-031650 Wang, 1999, [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated serum thyroglobulin levels, J Clin Endocrinol Metab, 84, 2291, 10.1210/jc.84.7.2291 Helal, 2001, Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy, J Nuclear Med, 42, 1464 Chin, 2004, Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma, J Clin Endocrinol Metab, 89, 91, 10.1210/jc.2003-031027 Nahas, 2005, The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma, Laryngoscope, 115, 237, 10.1097/01.mlg.0000154725.00787.00 Robbins, 2006, Real-time prognosis for metastatic thyroid carcinoma based on FDG-PET scanning, J Clin Endocrinol Metab, 91, 498, 10.1210/jc.2005-1534 Schlumberger, 2004, Follow-up and management of differentiated thyroid carcinoma: European perspective in clinical practice, Eur J Endocrinol, 151, 539, 10.1530/eje.0.1510539 Schlumberger, 2000, Clinical use of recombinant human TSH in thyroid cancer patients, Eur J Endocrinol, 143, 557, 10.1530/eje.0.1430557 Mazzaferri, 2003, A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma, J Clin Endocrinol Metab, 88, 1433, 10.1210/jc.2002-021702 Leeper, 1973, The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma, J Clin Endocrinol Metab, 36, 1143, 10.1210/jcem-36-6-1143 Beierwaltes, 1982, Survival time and ‘cure’ in papillary and follicular thyroid carcinoma with distant metastases: statistics following University ofMichigan therapy, J Nuclear Med, 23, 561 Bernier, 2001, Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas, J Clin Endocrinol Metab, 86, 1568, 10.1210/jc.86.4.1568 Pacini, 1994, Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine, World J Surg, 18, 600, 10.1007/BF00353775 Pons, 1987, Lithium as an adjuvant of iodine-131 uptake when treating patients with well-differentiated thyroid carcinoma, Clin Nuclear Med, 12, 644, 10.1097/00003072-198708000-00014 Koong, 1999, Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma, J Clin Endocrinol Metab, 84, 912, 10.1210/jc.84.3.912 Zettinig, 2002, Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy?, Clin Endocrinol (Oxford), 56, 377, 10.1046/j.1365-2265.2002.01482.x Pittas, 2000, Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred fortysix patients, Thyroid, 10, 261, 10.1089/thy.2000.10.261 Schlumberger, 1996, Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma, J Nuclear Med, 37, 598 Marcocci, 1989, Clinical and biological behaviour of bone metastases from differentiated thyroid carcinoma, Surgery, 106, 960 McWilliams, 2003, Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years, Cancer, 98, 356, 10.1002/cncr.11488 Mandel, 2003, Radioactive iodine and the salivary glands, Thyroid, 13, 265, 10.1089/105072503321582060 Nakada, 2005, Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?, J Nuclear Med, 46, 261 Ceccarelli, 1999, Radiation dose to the testes after 131-I therapy for ablation of post-surgical thyroid remnants in patients with differentiated thyroid cancer, J Nuclear Med, 40, 1716 Pacini, 1994, Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine, J Nuclear Med, 35, 1418 Schlumberger, 1996, Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients, J Nuclear Med, 37, 606 Ceccarelli, 2001, 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study, J Clin Endocrinol Metab, 86, 3512, 10.1210/jc.86.8.3512 Rubino, 2003, Second primary malignancies in thyroid cancer patients, Br J Cancer, 89, 1638, 10.1038/sj.bjc.6601319 De Vathaire, 1997, Leukaemias and cancers following iodine-131 administration for thyroid cancer, Br J Cancer, 75, 734, 10.1038/bjc.1997.130 Ford, 2003, External beam radiotherapy in the management of differentiated thyroid cancer, Clin Oncol, 15, 337, 10.1016/S0936-6555(03)00162-6 Mazzarotto, 2000, The role of external beam radiotherapy in the management of differentiated thyroid cancer, Biomed Pharmacother, 54, 345, 10.1016/S0753-3322(00)80061-X Droz, 1990, Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy, Tumori, 76, 480, 10.1177/030089169007600513 Pacini, 1984, Treatment of refractory thyroid cancer with adriamycin, Drugs Exper Clin Res, 10, 911 Haugen, 1999, Management of the patient with progressive radioiodine non-responsive disease, Semin Surg Oncol, 16, 34, 10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2 Santini, 2002, Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer, J Clin Endocrinol Metab, 87, 4160, 10.1210/jc.2001-011151 Braga-Brasaria, 2003, Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer, J Clin Endocrinol Metab, 88, 1947, 10.1210/jc.2002-021863